EUVIMEDEUVIMED entdecken
Crossref

ADAM10 as a major activator of reactive oxygen species production and klotho shedding in podocytes under diabetic conditions

Agnieszka Piwkowska, Patrycja Rachubik, Marlena Typiak, Tomasz Kulesza, Irena Audzeyenka, Moin A Saleem, Natalia Gruba, Magdalena Wysocka, Adam Lesner, Dorota Rogacka

Biochemical Pharmacology · 2024

DOI: 10.1016/j.bcp.2024.116328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Agnieszka Piwkowska und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mossakowski Medical Research Institute, Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Gdańsk, Poland; University of Gd…. Hauptthemen laut MEDLINE: Podocytes, Klotho Proteins, ADAM10 Protein, Reactive Oxygen Species. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Science Centre Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early stages of diabetes are characterized by elevations of insulin and glucose concentrations. Both factors stimulate reactive oxygen species (ROS) production, leading to impairments in podocyte function and disruption of the glomerular filtration barrier. Podocytes were recently shown to be an important source of αKlotho (αKL) expression. Low blood Klotho concentrations are also associated with an increase in albuminuria, especially in patients with diabetes. We investigated whether ADAM10, which is known to cleave αKL, is activated in glomeruli and podocytes under diabetic conditions and the potential mechanisms by which ADAM10 mediates ROS production and disturbances of the glomerular filtration barrier. In cultured human podocytes, high glucose increased ADAM10 expression, shedding, and activity, NADPH oxidase activity, ROS production, and albumin permeability. These effects of glucose were inhibited when cells were pretreated with an ADAM10 inhibitor or transfected with short-hairpin ADAM10 (shADAM10) or after the addition soluble Klotho. We also observed increases in ADAM10 activity, NOX4 expression, NADPH oxidase activity, and ROS production in αKL-depleted podocytes. This was accompanied by an increase in albumin permeability in shKL-expressing podocytes. The protein expression and activity of ADAM10 also increased in isolated glomeruli and urine samples from diabetic rats. Altogether, these results reveal a new mechanism by which hyperglycemia in diabetes increases albumin permeability through ADAM10 activation and an increase in oxidative stress via NOX4 enzyme activation. Moreover, αKlotho downregulates ADAM10 activity and supports redox balance, consequently protecting the slit diaphragm of podocyteσ under hyperglycemic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesKlotho ProteinsADAM10 ProteinReactive Oxygen SpeciesGlucuronidaseAmyloid Precursor Protein SecretasesMembrane ProteinsDiabetes Mellitus, ExperimentalHumansAnimalsRatsMaleNADPH Oxidase 4NADPH OxidasesCells, CulturedGlucoseRats, Sprague-Dawley

Stichwörter der Autor:innen

ADAM10DiabetesGlomerular filtration barrierNADPH oxidaseNOX4PodocyteαKlotho

Substanzen

Klotho ProteinsADAM10 ProteinReactive Oxygen SpeciesADAM10 protein, humanGlucuronidaseAmyloid Precursor Protein SecretasesMembrane ProteinsNADPH Oxidase 4KL protein, humanNADPH Oxidases

Autor:innen und Institutionen

  • Mossakowski Medical Research Institute, Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Gdańsk, Poland; University of Gdansk, Faculty of Chemistry, Gdańsk, Poland. Electronic address: apiwko…
  • Mossakowski Medical Research Institute, Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Gdańsk, Poland.
  • University of Gdansk, Faculty of Biology, Gdansk, Poland.
  • Mossakowski Medical Research Institute, Polish Academy of Sciences, Laboratory of Molecular and Cellular Nephrology, Gdańsk, Poland; University of Gdansk, Faculty of Chemistry, Gdańsk, Poland.
  • Bristol Renal, University of Bristol, Bristol, United Kingdom.
  • University of Gdansk, Faculty of Chemistry, Gdańsk, Poland.

Förderung

  • National Science Centre Poland

Zitieren

APA

Piwkowska, A., Rachubik, P., Typiak, M., Kulesza, T., Audzeyenka, I., Saleem, M. A., Gruba, N., Wysocka, M., Lesner, A., & Rogacka, D. (2024). ADAM10 as a major activator of reactive oxygen species production and klotho shedding in podocytes under diabetic conditions. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116328

Vancouver

Piwkowska A, Rachubik P, Typiak M, Kulesza T, Audzeyenka I, Saleem MA, et al. ADAM10 as a major activator of reactive oxygen species production and klotho shedding in podocytes under diabetic conditions. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116328

BibTeX
@article{Piwkowska2024,
  author = {Piwkowska, Agnieszka and Rachubik, Patrycja and Typiak, Marlena and Kulesza, Tomasz and Audzeyenka, Irena and Saleem, Moin A and Gruba, Natalia and Wysocka, Magdalena and Lesner, Adam and Rogacka, Dorota},
  title = {ADAM10 as a major activator of reactive oxygen species production and klotho shedding in podocytes under diabetic conditions},
  journal = {Biochemical Pharmacology},
  year = {2024},
  doi = {10.1016/j.bcp.2024.116328}
}
Kostenlos starten →